News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Personnel (World)
AmpliPhi Biosciences Corporation (APHB) Announces Departure Of CEO 9/19/2014
Celgene (CELG) Appoints Tuomo Pätsi As President Of EMEA And Commits To Continue Delivering Innovative Solutions To Meet Patient Needs Across The Region 9/19/2014
Mary Tanner Appointed To Genticel’s Supervisory Board As Independently-Acting Member 9/19/2014
Horizon Pharma plc.  (HZNP) Announces Board Of Directors Following Closing Of Acquisition Of Vidara Therapeutics International plc 9/19/2014
Merck KGaA (MKGAF.PK) Appoints New Deputy Chief As CEO Kley’s Succession Is Pondered 9/18/2014
Nexvet Expands Australian Veterinary Biologics Research Centre 9/15/2014
Scientific Founder Of Intercept Pharmaceuticals (ICPT) Joins Tiziana Life Sciences Plc 9/12/2014
Medgenics, Inc. Announces The Appointment Of Scott Applebaum As Chief Legal Officer 9/10/2014
To-BBB technologies BV Taps A New CEO 9/9/2014
Bruno Lucidi New CEO In Karolinska Development AB Oncology Companies 9/8/2014
CollPlant Names Dr. Nadav Orr Vice President Research And Development 9/8/2014
Aptose Biosciences Recruits Stephen B. Howell, M.D. To Act In The Capacity Of Chief Medical Officer 9/8/2014
Pivotal Therapeutics Inc. Appoints Accomplished Healthcare And Investment Industry Veteran, Prakash Gowd, As Chief Financial Officer 9/8/2014
Ex-Genentech (RHHBY) Boss Resigns From Roche (RHHBY)'s Board; Fears Conflict Of Interest With New CEO Post At Google Inc.'s Calico 9/4/2014
Nabriva Therapeutics Appoints Dr. Colin Broom As CEO 9/3/2014
ICON Appoints Dr. Ira Spector As Executive Vice President, Analytics And Consulting 9/3/2014
Cerenis Therapeutics, Inc. Appoints Dr. Richard C. Pasternak As Chairman 9/3/2014
TiGenix Appoints Chief Medical Officer And Vice President Medical Affairs And New Product Commercialisation 9/2/2014
Shareholders Revolt Over GlaxoSmithKline (GSK)'s Plans To Shake Up Board; Investors Call For Speedy Departure Of Chairman Gent 9/2/2014
Sierk Pötting To Be The New CFO (Chief Financial Officer) Of BioNTech Group 9/2/2014
Amarantus BioSciences, Inc. Appoints Iain Ross To Board Of Directors 8/29/2014
Isogenica Limited Brings In A New CEO 8/28/2014
Moberg Pharma AB (Formerly known as Moberg Derma)’s Head Of U.S. Operations To Resign By End Of January 2015 8/28/2014
Appointment Announcement - Dr. Jeremy B. Desai, President and CEO, Apotex Inc. 8/27/2014
Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO 8/26/2014
Miriam Monge To Join Sartorius Stedim Biotech As Director Of Marketing For Integrated Solutions 8/26/2014
Pharmaceutical Executive Joins Mesoblast Limited (MSB.AX) As Chief Financial Officer 8/25/2014
Compugen Ltd. (CGEN) Appoints Mr. Ari Krashin As Chief Financial Officer 8/25/2014
More Exits From Ranbaxy Laboratories (RANBAXY.BO)' Top Management Team 8/21/2014
ELC Group Appoints Dr. Siddharth Chachad As Head Of Global Clinical Development And Medical Affairs 8/20/2014
Masters Speciality Pharma Appoints Partner Development Director 8/19/2014
Dr. Paul Blake To Take Executive Role As Chief Development Officer 8/15/2014
Forward Pharma Announces Appointment Of Dr. Jan G. J. Van De Winkel To Board Of Directors 8/13/2014
GE Healthcare Life SciencesOlivier Loeillot Appointed GM Asia Commercial Bioprocess 8/13/2014
Ex-Merck & Co., Inc. (MRK) Exec Appointed New President And CEO Of Medivir AB (MVRBF) 8/12/2014
Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma As Chief Financial Officer 8/11/2014
GlaxoSmithKline (GSK) Close To Poaching Royal Bank of Scotland (RBS)'s Sir Philip Hampton As Next Chairman 8/8/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of Walter Kwauk To Board 8/8/2014
Cortendo Appoints Matthew Pauls As CEO 8/7/2014
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving 8/1/2014
Rafarma Pharmaceuticals Announces New President As Part Of Pending Acquisition Of Majority Interest 7/30/2014
ImaginAb, Inc. Appoints Roger Crystal, MD As Vice President of Business Development 7/28/2014
Amarantus BioSciences, Inc. Appoints Donald D. Huffman To Board Of Directors 7/28/2014
Management Reshuffle At Ranbaxy Laboratories (RANBAXY.BO): Arno Gessner Promoted, New R&D Head Named 7/28/2014
Bristol-Myers Squibb Company (BMY) Appoints Jitendra Tyagi As India Country Head 7/24/2014
Milestone Pharmaceuticals Appoints Chief Medical Officer 7/21/2014
Peptidream Announces The Appointment Of Dr. Keiichi Masuya As Chief Operating Officer (COO) At Peptidream Inc. 7/17/2014
Antibe Therapeutics Inc. Announces The Formation Of Its Clinical Advisory Board 7/17/2014
Teva Pharmaceutical Industries Limited (TEVA) Denies Shareholder Claim That A Chairman Has Been Selected 7/15/2014
Merck KGaA (MKGAF.PK) Hires A New Global Head Of R&D 7/15/2014
Immune Pharmaceuticals, Inc. Appoints Cameron Durrant, MD, MBA To Board Of Directors 7/14/2014
ScinoPharm President & CEO To Retire, Successor Named 7/11/2014
Prima Biomed (PRR.AX) Appoints New Chief Executive Officer 7/9/2014
Director Ying Han Resigns from WuXi PharmaTech Co., Ltd. Board 7/9/2014
Michael Balmuth Joins SV Life Sciences As Partner 7/8/2014
Oxford BioTherapeutics Appoints Dr. Eugen Leo As Head Of Clinical Development 7/8/2014
Oxford Immunotec Limited (OXFD) Appoints Louis O'Dea Chief Medical Officer 7/7/2014
Pharmalink AB Strengthens its Board Of Directors 7/7/2014
VolitionRX Announces New Chief Financial Officer 7/1/2014
ALK-Abello A/S Appoints New Executive Vice President For Product Supply 7/1/2014
ProSensa Holding N.V. (RNA) Strengthens Its Management Team And Supervisory Board With Key Appointments 6/30/2014
Ipsen (IPN.PA) Joins PHARNEXT's Board Of Directors 6/30/2014
Serial Entrepreneur Dr. Peter Hirth Joins Nuevolution As Corporate Advisor 6/26/2014
Helsinn Therapeutics (US) Inc. Strengthens Its Board Of Directors 6/25/2014
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014
With Boardroom Drama Behind Him, Teva Pharmaceutical Industries Limited (TEVA) Chairman Phillip Frost To Step Down By End Of The Year 6/19/2014
PSI Names Jim Kostka, Director of Project Management, North America 6/18/2014
Valeant Pharmaceuticals International (VRX) Announces Planned Management Departure 6/16/2014
Protalix Biotherapeutics, Inc. (PLX) CEO Will Retire This Year 6/13/2014
Pivotal Therapeutics Inc. Engages Kilmer Lucas For Cross-Border Investor Relations 6/12/2014
Foamix Establishes U.S. Subsidiary And Strengthens Executive Management With Appointment Of Senior U.S. Leadership Team 6/12/2014
Aerocrine Announces Leadership Changes 6/12/2014
AstraZeneca PLC (AZN) Investors Still Want To Link Executive Pay To Pipeline Delivery 6/11/2014
DNA Electronics Ltd. Appoints Nick McCooke As Chief Business Officer 6/10/2014
Israel Stem Cell Developer BrainStorm Cell Therapeutics Inc. Appoints Tony Fiorino, MD, PhD As CEO 6/9/2014
Chiltern International Ltd. And Society For Applied Pharmacological Sciences (SSFA) Announce The Appointment Of Dr. Marco Romano As President Of SSFA 6/9/2014
Immune Pharmaceuticals, Inc. Appoints Gad Berdugo To Board Of Directors And Karin Hehenberger, M.D., Ph.D To Senior Vice President 6/6/2014
Dieter Weinand Tapped To Be President Of Bayer HealthCare Pharmaceuticals (BAYA.F) 6/6/2014
Bayer AG (BAYZF)'s CEO To Quit In 2016, CFO Moves Over To Lead Strategy 6/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Reorganizes, Makes Senior Leadership Changes 6/4/2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus As Chief Medical Officer 6/3/2014
Anergis Appoints Dr. Vanya Beltrami As Director Product Development 6/3/2014
Kymab Strengthens Management Team With Two Senior Appointments 6/3/2014
Novartis AG (NVS) Appoints Merck & Co., Inc. (MRK) Executive As Cancer Chief 6/3/2014
MGB Biopharma Limited Expands Scientific Advisory Board (SAB) With Medical Microbiologist Dr Stephanie Dancer 6/2/2014
Ascendis Pharma A/S Appoints Martin Auster, M.D., As Chief Business Officer 6/2/2014
SV Life Sciences Appoints Three New Venture Partners 6/2/2014
Gensignia Appoints CEO 5/30/2014
Bavarian Nordic (BAVA.CO) Taps Paul Chaplin, Ph.D. For President & CEO Post 5/29/2014
Chiltern International Ltd. Appoints Dr. Michael Wisniewski As Senior Executive Director, Biometrics 5/28/2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) With Experts In Chronic Pain 5/27/2014
Swedish Orphan BiovitrumAppoints Kirsti Gjellan As Senior Vice President Manufacturing Operations 5/27/2014
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014
Appointment Of Jens Klein As Managing Director Of AMSilk GmbH 5/23/2014
AmpliPhi Biosciences Corporation (APHB) Announces Appointment of New Board Member 5/23/2014
Oncolytics Biotech Inc. (ONC.TO) Announces Nomination Of Two New Directors 5/22/2014
Dr. Brian Zambrowicz, Ph.D Has Joined Nuevolution As Director And Senior Scientific Advisor To The Board Of Directors 5/21/2014
Peter George Joins Board Of ErgoMed As Non-Executive Director 5/21/2014
Jazz Pharmaceuticals plc (JAZZ) Names Russell J. Cox To Position Of Chief Operating Officer 5/20/2014
Symphogen A/S Finds A New Home, Appoints Chief Manufacturing Officer 5/19/2014
Avastin And Lucentis Pioneer Joins Tiziana Life Sciences 5/19/2014
Pivotal Therapeutics Inc. Announces Changes To The Board Of Directors 5/15/2014
Karolinska Development AB Appoints New Board Directors 5/15/2014
World Leader In Movement Disorders Professor Ira Shoulson Joins PRANA Biotechnology (PRAN) Board 5/14/2014
Compugen Ltd. (CGEN) Appoints Mr. Avihai Shen Interim CFO 5/12/2014
Antibe Therapeutics Inc. Announces Addition To Its Board Of Directors And Grant Of Options 5/12/2014
MediWound (MDWD) Completes Recruitment Of Commercial Management Team In Europe 5/12/2014
PROMETHERA Biosciences S.A./N.V. Welcomes Frank Hazevoets As Chief Financial Officer 5/12/2014
Annette Clancy Joins Swedish Orphan Biovitrum's Board Of Directors 5/9/2014
Elekta Announces Changes To Its Executive Management Team 5/8/2014
DNA Electronics Ltd. Appoints Dr Steve Allen As Chief Operating Officer; Expands Product Development Team 5/8/2014
Scil Proteins GmbH Brings In A New CEO 5/8/2014
GW Pharmaceuticals Appoints Dr. Kenneth Sommerville As VP, Clinical Science 5/6/2014
Cobra Biologics Ltd. Appoints CSO 5/6/2014
QRxPharma Ltd. (QRXPY) COO Promoted To Top Post 5/2/2014
Marken Announces Appointment Of Chief Financial Officer Steve Menzies Joins As New CFO And Board Director 5/1/2014
Niklas Savander Assumes Role As Elekta's New President And CEO 5/1/2014
Endo Appoints Dr. Hemanth J. Varghese As Executive Vice President Of Corporate Development And Strategy 4/29/2014
Recipharm AB Appoints New Directors, Business Management To Further Strengthen European Sales Drive 4/29/2014
Kapil Dhingra, Former Head Of Roche Oncology, Joins Advanced Accelerator Applications Board Of Directors 4/29/2014
Galapagos NV (GLPG.BR) Announces Management Change 4/28/2014
AstraZeneca PLC (AZN) Investors Enraged, Revolt Over Executive Pay Plans 4/28/2014
Chugai Pharma USA, LLC. Announces Appointment Of Chief Medical Officer 4/25/2014
Bavarian Nordic (BAVA.CO) Welcomes Gerard Van Odijk As New Chairman Of The Board 4/25/2014
Pivotal Therapeutics Inc. Announces Resignation Of Directors 4/24/2014
Actavis (ACT) Announces Departure Of G. Frederick Wilkinson, President, Actavis Global R&D 4/21/2014
Lupin Pharmaceuticals, Inc. Appoints Theresa Stevens As Chief Corporate Development Officer 4/21/2014
Merck Serono's President & CEO Belén Garijo Has Been Appointed To Board Of Directors Of L'Oréal 4/18/2014
Results Of Election Of Employee Elected Member Of Zealand Pharma  (ZEAL.CO)’s Board Of Directors 4/17/2014
Professor Raymond Schinazi Joins Board Of reViral As Non-Executive Director 4/15/2014
New VP Sales, Michael Rossi, Appointed At Jubilant Draximage Inc. 4/10/2014
uniQure Announces Changes In Management Team 4/9/2014
Novartis AG (NVS) Names New Heads Of Alcon, Inc. (ACL), Sandoz, Inc. Units 4/9/2014
Atrium Innovations Announces Management Transition 4/8/2014
DBV Technologies Announces Creation Of US Subsidiary And Appoints Ms. Susanna Mesa As Vice President Of Finance, U.S. Investor Relations & Strategy 4/7/2014
e-Therapeutics plc Announces Directorate Change 4/7/2014
e-Therapeutics plc Announces That Steve Medlicott Has Been Appointed Finance Director 4/7/2014
Global Regulatory Affairs Specialist ELC Group Appoints Senior Regulatory Expert 4/3/2014
Top Novartis AG (NVS) Execs In Japan Quit Over Cancer Drug Scandal, Replacements Appointed 4/3/2014
Immune Pharmaceuticals, Inc. CEO Announces New Operational Leadership Team 4/2/2014
Proposal Of The Election Committee Regarding Members Of The Board Etc. For Vitrolife (VITR.ST) 3/31/2014
Meda AB (MEDA-A.ST) Release: Nomination Committee’s Proposal For Composition Of The Board 3/28/2014
Cambridge-Based Regenerys Brings In Ex-GE Healthcare Exec For Top Post 3/28/2014
Adaptimmune Ltd. Announces Full-Time Appointment Of James Noble As Chief Executive Officer 3/26/2014
Immunocore Limited Announces Re-Organisation Of Its Executive Management To Support Business Growth 3/26/2014
AstraZeneca PLC (AZN) CEO Gets A Bigger Bonus In 2013 3/25/2014
In Another Top Management Move, Takeda Pharmaceutical Co. Ltd. (TKPYY) Appoints New Emerging Markets Chief 3/20/2014
CiToxLAB Appoints John C. Kapeghian As Senior Director Of Toxicology In North America 3/18/2014
Medivir AB (MVRBF): The Nomination Committee’s Proposal, With Reference To The Upcoming 2014 Annual General Meeting, For A New Board Of Directors 3/14/2014
Formycon AG Appoints Top U.S. Pharmaceuticals Manager Bernhard Hampl To The Advisory Board 3/13/2014
NovImmune SA Appoints Andrew J. Oakley As CFO 3/12/2014
Novella Clinical Names Dr. Chris Smyth Managing Director Of European And Asian Operations 3/11/2014
Award-Winning Scientist Dr. Susan M. Dallabrida Promoted To Vice President Of Clinical Science And Consulting Of PHT Corporation 3/11/2014
Royal DSM Proposes Appointment Of New Chief Financial Officer 3/10/2014
Veloxis Pharmaceuticals A/S (VELO) Promotes John Weinberg To Chief Operating Officer 3/6/2014
Teva Pharmaceutical Industries Limited (TEVA) Returns To Roots After "Nuthouse" Board Ousts CEO 3/6/2014
Novogen Limited (NVGN) Appoints New Board Members And Strategic Advisor To Support Transition To Clinical Development And Growing International Presence 3/4/2014
IP Group Appoints Professor Lynn Gladden As Non-Executive Director 3/4/2014
Novasep Appoints CEO Michel Spagnol As Chairman Of The Supervisory Board 3/4/2014
Amakem Therapeutics Appoints Dr. James Tsai Of The Yale School Of Medicine To Its Clinical Advisory Board 3/4/2014
BeiGene Co.,Ltd Announces Addition Of Dr. Ronald Levy To Scientific Advisory Board 3/3/2014
Canbex Therapeutics Announces The Appointment Of New Chief Medical Officer 3/3/2014
PSI CRO Names Dr. Gabriele Schmoetzer, Head Of Regulatory Affairs Germany 2/26/2014
WuXi PharmaTech Co., Ltd. Announces Appointment Of Dr. Hua Mu To Head Product Development Service And Partnership Business Unit 2/26/2014
Jazz Pharmaceuticals plc (JAZZ) Announces Management Change 2/26/2014
Faculty Of 1000 Appoints New CEO 2/25/2014
Alchemia Appoints Thomas Liquard As Chief Executive Officer 2/24/2014
INC Research, Inc. Appoints 30-Year Industry Veteran Jane Winter To Lead Global Consulting Practice 2/24/2014
Laurence Burke Joins Exco Intouch As Vice President Of Operations 2/19/2014
Alcobra (ADHD) Appoints J.P. Morgan Banker Dr. Tomer Berkovitz As Chief Financial Officer 2/19/2014
Lupin Ltd. (LUPN.BO) Appoints Dr. Maurice Chagnaud As President-Europe & Head Of Inhalation Strategy 2/18/2014
Complementing Recommendation By The Nomination Committee Of Oriola-KD Corporation Concerning The Board Of Directors To Be Elected By The 2014 Annual General Meeting 2/18/2014
Avillion Appoints Dr. Allison Jeynes-Ellis As Chief Executive Officer 2/18/2014
Emperra Appoints Christian Krey As New CEO To Market ESYSTA® Telediabetology System 2/11/2014
Medical Key Opinion Leaders In Preeclampsia Join Pluristem Therapeutics (PSTI)'s Steering Committee 2/11/2014
Novogen Limited (NVGN) Announces Key Appointments To Drive Development Of Anti-Tropomyosin Drug Platform 2/5/2014
Pluristem Therapeutics (PSTI) Strengthens Executive Team; Announces Senior Executive Appointments 2/5/2014
Amarin Corporation PLC (AMRN) Announces Promotion Of Aaron Berg To Senior Vice President, Marketing And Sales 2/4/2014
NicOx SA (COX.PA) Appoints Evelyne Nguyen As CFO 2/4/2014
Aesica Appoints Ian Muir To Newly Created Commercial Managing Director Position 2/3/2014
Sartorius AG Appoints Internationally Experienced Laboratory Manager To Join Its Top Management Team 1/30/2014
Novartis AG (NVS) Keeps CEO Pay Steady, But Incoming Chairman Pay Drops 1/29/2014
Merck KGaA (MKGAF.PK) Shaken Due To CFO's Surprise Exit 1/28/2014
Lanxess AG (LXS.F) Names Former CFO Zachert As CEO Displacing Heitmann 1/27/2014
Susan Kilsby To Succeed Matthew Emmens As Chairman Of Shire 1/23/2014
Teva Pharmaceutical Industries Limited (TEVA) To Reduce Size Of Its Board, Add Experts 1/23/2014
Compugen Ltd. (CGEN) Announces Addition Of Prof. Drew Pardoll To Its Scientific Advisory Board 1/21/2014
Imugene Limited (IMU.AX) Appoints Distinguished Scientists To Scientific Advisory Board 1/20/2014
Alacrita Appoints Pierre Dodion As An Associate Partner 1/20/2014
NextPharma Technologies Continues To Strengthen Its Business With Three Senior Appointments 1/20/2014
INC Research, Inc. Strengthens Oncology Team With Two Key Appointments 1/20/2014
ICON Appoints Dr. Dariush Elahi As Head Of Metabolic Research, Early Phase 1/20/2014
Novasep Attracts Top Talent To Complete Its Executive Team 1/16/2014
Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD To Its Board Of Directors 1/15/2014
Actavis (ACT) Appoints Industry Veterans To Lead U.S. Specialty Brands Business Units 1/14/2014
Tyco Files Proxy Statement And Proposes Election Of New Directors 1/13/2014
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer 1/13/2014
Alcobra (ADHD) Strengthens Management Team With Addition Of Industry Veteran David C. Baker As Chief Commercial Officer 1/13/2014
Novartis AG (NVS) Head, Herve Hoppenot, Flys The Coop To Become CEO Of Incyte Corporation (INCY) 1/13/2014
Galderma Pharma S.A. Announces CEO For North American Operations 1/10/2014